Neuroendocrine Tumor of Terminal Ileum - Case Report
Ramalho DW1, Mazzini lR1*, Júnior HS2, Camargo JGT2 and Mazzini H3
1Medical Student, Department of Gastroenterology, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Brazil
2Assistant Physician of the Surgery, Urgency and Trauma Service (SCUT) of the Celso Pierro Hospital and Maternity, Puc-Campinas Hospital, Brazil
3Assistant Physician of the General Surgery Service of the Paulínia Municipal Hospital, Brazil
*Corresponding Author: Mazzini lR, Medical Student, Department of Gastroenterology, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Brazil.
Received:
June 17, 2022; Published: June 27, 2022
Abstract
Neuroendocrine tumors are malignancis associated or not with hormonal changes, presenting indolently. It has a variable incidence according to the type of study, but usually 0,28-0,8:100.000 [10] is observed, but it may be even rarer depending on its location. The aim of this study is to report a rare case of neuroendocrine tumor of the small intestine diagnosed by unusual methods.
Keywords: Tumor; Neuroendocrine; Indolent
References
- Araújo NAA., et al. “Tumores neuroendócrinos: revisão de literatura”. Perspectivas Médicas 1 (2012): 35-41.
- Linhares E., et al. “Tumores neuroendócrinos do intestino delgado: experiência do Instituto Nacional de Câncer em 12 anos”. Gastrenterologia Endoscopia Digestiva 1 (2011): 7-12.
- Modlin IM., et al. “A five-decade analysis of 13,715 carcinoid tumors”. Cancer 97 (2003): 934-959.
- Fernandes LC., et al. “Diagnóstico e tratamento de tumores carcinóides do trato digestivo”. Revista da Associacao Medica Brasileira1 (2002): 87-92.
- Pinchot SN., et al. “Carcinoid Tumors”. Oncologist 12 (2008): 1255-1269.
- Hemminki K and Li X. “Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden”. Cancer 92 (2001): 2204-2210.
- Maggard M., et al. “Updated population-based review of carcinoid tumors”. Annals of Surgery 240 (2004): 117-122.
- Buitrago MHG., et al. “Tumor neuroendocrino del intestino delgado. Reporte de un caso singular”. Revista Colombiana de Cirugía 4 (2005): e1492.
- Deutsch GB., et al. “Long-term survival with long-acting somatostatin analogues plus aggressive cytoreductive surgery in patients with metastatic neuroendocrine carcinoma”. Journal of the American College of Surgeons 1 (2015): 26-36.
- Araújo NAA., et al. “Tumores neuroendócrinos: revisão de literatura”. Perspectivas Médicas1 (2012): 35-41.
- Mirica RE., et al. “Neuroendocrine tumour located in the small intestine, diagnosed by an abdominal ultrasound reassessment of liver haemangiomas”. Journal of Hepato-Gastroenterology 2 (2020): 1-4.
- Deguelte S., et al. “Surgery and perioperative management in small intestinal neuroendocrine tumors”. Journal of Clinical Medicine7 (2020): 2319.
- Gupta A., et al. “Small bowel neuroendocrine neoplasm: what surgeons want to know”. Abdominal Radiology (2021): 1-11.
- Pasquer A., et al. “Principles of Surgical Management of Small Intestinal NET”. Cancers21 (2021): 5473.
- Kennedy G., et al. “Routine ileal intubation during screening colonoscopy: a useful maneuver?” Surgical endoscopy12 (2008): 2606-2608.
- Cherian S and Singh P. “Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve”. Official Journal of the American College of Gastroenterology| ACG12 (2004): 2324-2329.
- Yusoff IF., et al. “Routine colonic mucosal biopsy and ileoscopy increases diagnostic yield in patients undergoing colonoscopy for diarrhea”. Journal of Gastroenterology and Hepatology3 (2002): 276-280.
Citation
Copyright